Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid

Abstract Background All-trans-retinoic-acid (ATRA) is a promising agent in the prevention/treatment of breast-cancer. There is growing evidence that reprogramming of cellular lipid metabolism contributes to malignant transformation and progression. Lipid metabolism is implicated in cell differentiat...

Full description

Bibliographic Details
Main Authors: Mineko Terao, Laura Goracci, Valentina Celestini, Mami Kurosaki, Marco Bolis, Alessandra Di Veroli, Arianna Vallerga, Maddalena Fratelli, Monica Lupi, Alessandro Corbelli, Fabio Fiordaliso, Maurizio Gianni, Gabriela Paroni, Adriana Zanetti, Gabriele Cruciani, Enrico Garattini
Format: Article
Language:English
Published: BMC 2019-10-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13046-019-1438-y
_version_ 1828907520340525056
author Mineko Terao
Laura Goracci
Valentina Celestini
Mami Kurosaki
Marco Bolis
Alessandra Di Veroli
Arianna Vallerga
Maddalena Fratelli
Monica Lupi
Alessandro Corbelli
Fabio Fiordaliso
Maurizio Gianni
Gabriela Paroni
Adriana Zanetti
Gabriele Cruciani
Enrico Garattini
author_facet Mineko Terao
Laura Goracci
Valentina Celestini
Mami Kurosaki
Marco Bolis
Alessandra Di Veroli
Arianna Vallerga
Maddalena Fratelli
Monica Lupi
Alessandro Corbelli
Fabio Fiordaliso
Maurizio Gianni
Gabriela Paroni
Adriana Zanetti
Gabriele Cruciani
Enrico Garattini
author_sort Mineko Terao
collection DOAJ
description Abstract Background All-trans-retinoic-acid (ATRA) is a promising agent in the prevention/treatment of breast-cancer. There is growing evidence that reprogramming of cellular lipid metabolism contributes to malignant transformation and progression. Lipid metabolism is implicated in cell differentiation and metastatic colonization and it is involved in the mechanisms of sensitivity/resistance to different anti-tumor agents. The role played by lipids in the anti-tumor activity of ATRA has never been studied. Methods We used 16 breast cancer cell-lines whose degree of sensitivity to the anti-proliferative action of ATRA is known. We implemented a non-oriented mass-spectrometry based approach to define the lipidomic profiles of each cell-line grown under basal conditions and following treatment with ATRA. To complement the lipidomic data, untreated and retinoid treated cell-lines were also subjected to RNA-sequencing to define the perturbations afforded by ATRA on the whole-genome gene-expression profiles. The number and functional activity of mitochondria were determined in selected ATRA-sensitive and –resistant cell-lines. Bio-computing approaches were used to analyse the high-throughput lipidomic and transcriptomic data. Results ATRA perturbs the homeostasis of numerous lipids and the most relevant effects are observed on cardiolipins, which are located in the mitochondrial inner membranes and play a role in oxidative-phosphorylation. ATRA reduces the amounts of cardiolipins and the effect is associated with the growth-inhibitory activity of the retinoid. Down-regulation of cardiolipins is due to a reduction of mitochondria, which is caused by an ATRA-dependent decrease in the expression of nuclear genes encoding mitochondrial proteins. This demonstrates that ATRA anti-tumor activity is due to a decrease in the amounts of mitochondria causing deficits in the respiration/energy-balance of breast-cancer cells. Conclusions The observation that ATRA anti-proliferative activity is caused by a reduction in the respiration and energy balance of the tumor cells has important ramifications for the therapeutic action of ATRA in breast cancer. The study may open the way to the development of rational therapeutic combinations based on the use of ATRA and anti-tumor agents targeting the mitochondria.
first_indexed 2024-12-13T17:55:20Z
format Article
id doaj.art-40bd665e026e46e08e4ecaa2f82ffbc4
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-12-13T17:55:20Z
publishDate 2019-10-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-40bd665e026e46e08e4ecaa2f82ffbc42022-12-21T23:36:24ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662019-10-0138112010.1186/s13046-019-1438-yRole of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acidMineko Terao0Laura Goracci1Valentina Celestini2Mami Kurosaki3Marco Bolis4Alessandra Di Veroli5Arianna Vallerga6Maddalena Fratelli7Monica Lupi8Alessandro Corbelli9Fabio Fiordaliso10Maurizio Gianni11Gabriela Paroni12Adriana Zanetti13Gabriele Cruciani14Enrico Garattini15Laboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCSDepartment of Chemistry, Biology and Biotechnology, University of PerugiaLaboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCSLaboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCSLaboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCSDepartment of Chemistry, Biology and Biotechnology, University of PerugiaLaboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCSLaboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCSDepartment of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCSDepartment of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri IRCCSDepartment of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri IRCCSLaboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCSLaboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCSLaboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCSDepartment of Chemistry, Biology and Biotechnology, University of PerugiaLaboratory of Molecular Biology, Istituto di Ricerche Farmacologiche Mario Negri IRCCSAbstract Background All-trans-retinoic-acid (ATRA) is a promising agent in the prevention/treatment of breast-cancer. There is growing evidence that reprogramming of cellular lipid metabolism contributes to malignant transformation and progression. Lipid metabolism is implicated in cell differentiation and metastatic colonization and it is involved in the mechanisms of sensitivity/resistance to different anti-tumor agents. The role played by lipids in the anti-tumor activity of ATRA has never been studied. Methods We used 16 breast cancer cell-lines whose degree of sensitivity to the anti-proliferative action of ATRA is known. We implemented a non-oriented mass-spectrometry based approach to define the lipidomic profiles of each cell-line grown under basal conditions and following treatment with ATRA. To complement the lipidomic data, untreated and retinoid treated cell-lines were also subjected to RNA-sequencing to define the perturbations afforded by ATRA on the whole-genome gene-expression profiles. The number and functional activity of mitochondria were determined in selected ATRA-sensitive and –resistant cell-lines. Bio-computing approaches were used to analyse the high-throughput lipidomic and transcriptomic data. Results ATRA perturbs the homeostasis of numerous lipids and the most relevant effects are observed on cardiolipins, which are located in the mitochondrial inner membranes and play a role in oxidative-phosphorylation. ATRA reduces the amounts of cardiolipins and the effect is associated with the growth-inhibitory activity of the retinoid. Down-regulation of cardiolipins is due to a reduction of mitochondria, which is caused by an ATRA-dependent decrease in the expression of nuclear genes encoding mitochondrial proteins. This demonstrates that ATRA anti-tumor activity is due to a decrease in the amounts of mitochondria causing deficits in the respiration/energy-balance of breast-cancer cells. Conclusions The observation that ATRA anti-proliferative activity is caused by a reduction in the respiration and energy balance of the tumor cells has important ramifications for the therapeutic action of ATRA in breast cancer. The study may open the way to the development of rational therapeutic combinations based on the use of ATRA and anti-tumor agents targeting the mitochondria.http://link.springer.com/article/10.1186/s13046-019-1438-yRetinoic acidBreast cancerLipidomicsOxidative phosphorylation
spellingShingle Mineko Terao
Laura Goracci
Valentina Celestini
Mami Kurosaki
Marco Bolis
Alessandra Di Veroli
Arianna Vallerga
Maddalena Fratelli
Monica Lupi
Alessandro Corbelli
Fabio Fiordaliso
Maurizio Gianni
Gabriela Paroni
Adriana Zanetti
Gabriele Cruciani
Enrico Garattini
Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid
Journal of Experimental & Clinical Cancer Research
Retinoic acid
Breast cancer
Lipidomics
Oxidative phosphorylation
title Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid
title_full Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid
title_fullStr Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid
title_full_unstemmed Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid
title_short Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid
title_sort role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid
topic Retinoic acid
Breast cancer
Lipidomics
Oxidative phosphorylation
url http://link.springer.com/article/10.1186/s13046-019-1438-y
work_keys_str_mv AT minekoterao roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT lauragoracci roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT valentinacelestini roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT mamikurosaki roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT marcobolis roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT alessandradiveroli roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT ariannavallerga roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT maddalenafratelli roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT monicalupi roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT alessandrocorbelli roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT fabiofiordaliso roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT mauriziogianni roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT gabrielaparoni roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT adrianazanetti roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT gabrielecruciani roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid
AT enricogarattini roleofmitochondriaandcardiolipinsingrowthinhibitionofbreastcancercellsbyretinoicacid